Skip to main content
Download PDF
  • Research Article
  • Open access
  • Published:

Effects and mechanism of renal denervation on ventricular arrhythmia after acute myocardial infarction in rats

BMC Cardiovascular Disorders volume 22, Article number: 544 (2022) Cite this article

Abstract

Background

Renal denervation (RDN) can reduce ventricular arrhythmia after acute myocardial infarction (AMI), but the mechanism is not clear. The purpose of this study is to study its mechanism.

Methods

Thirty-two Sprague–Dawley rats were divided into four groups: control group, AMI group, RDN-1d + AMI group, RDN-2w + AMI group. The AMI model was established 1 day after RDN in the RDN-1d + AMI group and 2 weeks after RDN in the RDN-2w + AMI group. At the same time, 8 normal rats were subjected to AMI modelling (the AMI group). The control group consisted of 8 rats without RDN intervention or AMI modelling.

Results

The study confirmed that RDN can reduce the occurrence of ventricular tachycardia in AMI rats, reduce renal sympathetic nerve discharge, and inhibit the activity of local sympathetic nerves and cell growth factor (NGF) protein expression in the heart after AMI. In addition, RDN decreased the expression of norepinephrine (NE) and glutamate in the hypothalamus,and NE in cerebrospinal fluid, and increased the expression level of γ aminobutyric acid (GABA) in the hypothalamus after AMI.

Conclusion

RDN can effectively reduce the occurrence of ventricular arrhythmia after AMI, and its main mechanism may be via the inhibition of central sympathetic nerve discharge.

Peer Review reports

Background

Acute myocardial infarction (AMI) refers to the acute and persistent insufficiency of coronary blood supply leading to myocardial ischaemic necrosis. The incidence of AMI is increasing every year, the affected population tends to be younger, and AMI has become one of the major diseases that cause death and disability in humans. Ventricular arrhythmia caused by AMI is the main factor leading to sudden cardiac death and an indicator of poor prognosis of patients [1]. Cardiac sympathetic nerve remodelling and abnormal excitation after AMI are important causes of ventricular arrhythmia [2]. Renal denervation (RDN) is an interventional procedure that has emerged in recent years. It can inhibit the activation of the renin angiotensin aldosterone system (RAAS) and decrease systemic sympathetic nerve activity. Initially, RDN was mainly used to treat hypertension, but now more and more evidence shows that RDN is beneficial also to other entities including heart failure, arrhythmia, cardiac hypertrophy [3,4,5,6]. Studies have shown that RDN can inhibit the occurrence of ventricular arrhythmia during ischemia/AMI [7]. At the same time, a number of clinical studies have confirmed that RDN can effectively reduce various types of ventricular arrhythmias [8,9,10,11,12,13], but its mechanism of action is not clear. Aim of this study was to explore the effect of RDN on ventricular arrhythmias during ischemia/AMI and the underlying mechanism.

Methods

Animals

A total of 32 SD male rats, weighing 200–250 g, were purchased from Shanghai Slack Laboratory Animal Co., Ltd. (Certificate Number: 20170005043887) and were raised under standard conditions. All experimental procedures were approved by the Shanghai Medical Ethics Committee. The 32 SD rats were randomly divided into 4 groups by the random number method: the control group, AMI group, RDN-1d + AMI group, and RDN-2w + AMI group. There were 8 rats in each group, and models were established for the corresponding treatment.

RDN operation

Rats were fasted with access to water before the operation, weighed before anaesthesia, and then anaesthetized with intraperitoneal administration of 2.5% sodium pentobarbital solution (0.3 ml/100 g). After anaesthesia induction, the rats were placed flat and fixed in a supine position on the operating table with a rubber band. The abdominal skin was shaved with a razor and disinfected with a cotton ball soaked in 75% alcohol. A surgical incision was made on the abdominal centreline, sterile gauze soaked in saline was used to cover the intestines, and the bilateral renal artery was isolated. Then, sterile gauze strips soaked in 10% phenol solution with 95% ethanol were gently wrapped around both renal arteries for one week to keep the phenol from contacting the surrounding organs as much as possible, and the gauze covering was removed one minute later [14]. After the operation, the incisions were sutured layer by layer, and penicillin was injected for 3 consecutive days to prevent infection.

AMI model

SD rats were anaesthetized with 2.5% sodium pentobarbital solution (0.3 ml/100 g) by intraperitoneal injection, fixed, intubated and connected to a ventilator after anaesthesia. Electrodes were connected to the rat, and a PowerLab multichannel physiological recorder was used to collect signals. ECG acquisition software was used to set the measurement parameters. The chest was opened at the third intercostal space on the left side of the sternum to expose the left anterior descending coronary artery. Ligation was performed at the junction point of the distal 1/3 [14], and ECG monitoring showed that the ST segment remained elevated, indicating that establishment of the myocardial infarction model was successful. Then, the signals were recorded continuously for 1 h, and finally, the number of ventricular tachycardia events were counted with the software.

Histopathological examination

Fresh cardiac and renal artery tissue samples were removed and cleaned. Half of the samples were frozen at −80 °C, and the remaining samples were fixed with 4% paraformaldehyde solution and embedded in paraffin. Haematoxylin and eosin (HE) and tyrosine hydroxylase (TH) staining were used to evaluate the effectiveness of RDN in the renal artery and surrounding sympathetic nerves. Cardiac sympathetic nerve activity was detected by TH and nerve growth factor (NGF) staining.

Western blot

The myocardial tissue frozen at −80 °C was thawed, and the expression level of NGF in the infarcted area was detected by Western blotting.

Enzyme-linked immunosorbent assay (ELISA)

The hypothalamus and cerebrospinal fluid were extracted, and the levels of GABA, NE and glutamate in the hypothalamic tissue were quantified with ELISA; moreover, the level of NE in the cerebrospinal fluid was measured with ELISA.

Renal sympathetic nerve activity (RSNA)

After RDN, the rats were anaesthetized by intraperitoneal injection of 2.5% sodium pentobarbital solution (0.3 ml/100 g) and fixed, and the skin was prepared after anaesthesia. The back skin was cut with scissors, the subcutaneous tissue was cut, and the intersection of the abdominal aorta and the renal artery was fully exposed. Then, the left renal sympathetic nerve was located under a dissecting microscope and dissociated, and the free renal sympathetic nerve was gently placed on a bipolar silver wire recording electrode. The recorded discharge signal was amplified 1000 times through the preamplifier and recorded by the oscilloscope and the Power Lab/8SP instrument of the biological information sampling system, and the discharge waveform displayed in the oscilloscope was observed and determined to be renal sympathetic. After nerve discharge, the renal sympathetic nerve and the electrode were wrapped in silica gel for insulation. After the discharge was stable, the RSNA at the basal level was recorded. Then, the rats were euthanized by injection with an excessive amount of pentobarbital (800 mg/kg) to induce the maximum RSNA (usually occurring within 2–5 min after an overdose of anaesthesia). After the renal sympathetic nerve discharge activity stopped, the RSNA background noise value was recorded (generally occurring within 20–30 min after an overdose of anaesthesia). Finally, the RSNA was calculated and analysed according to the following formula: (basic RSNA-RSNA background noise value)/(maximum RSNA–RSNA background noise value) [15].

Statistical analysis

The data of each group are expressed as the mean ± standard deviation (\(\overline{x }\)± s), and the comparison between multiple sample means was performed by one-way analysis of variance. For data with a normal distribution, the pairwise comparison of means was performed with a t test. If the variances between the two groups were homogeneous, the LSD test was used; if not, the Games-Howell test was used. Data processing was performed by SPSS 24.0 software, and the difference was considered to be statistically significant when P < 0.05.

Results

The effect of RDN on the occurrence of ventricular arrhythmia during ischemia/AMI

Verification of the establishment of the AMI model was performed with a PowerLab multichannel recorder, and the output was observed for 1 h. The results showed that compared with the AMI group (331.2 ± 74.8), the RDN-1d + AMI group (112 ± 59.2, P < 0.001) and the RDN-2w + AMI group (151 ± 87.9, P = 0.003) exhibited a significantly reduction in the occurrence of ventricular tachycardia. Among the groups, the RDN-1d + AMI group showed a more significant decrease in frequency than the RDN-2w-AMI group (Fig. 1). One rat in the AMI group died of ventricular fibrillation, although none of the rats in either RDN group died of ventricular fibrillation.

Fig. 1
figure 1

A shows the occurrence frequency of ventricular tachycardia (VT), #RDN-1d + AMI group compared with AMI group, the occurrence frequency of VT decreased, P<0.001; *RDN-2w+AMI group compared with AMI group, VT The number of rapid occurrences decreased, P=0.003, and the difference was statistically significant. B shows the normal ECG of rats and the ECG manifestations of ventricular tachycardia and ventricular fibrillation after AMI

Full size image

HE and TH staining were used to evaluate the damaging effect of RDN on renal sympathetic nerves.

The formalin-fixed renal artery and surrounding sympathetic nerves were dehydrated, cleared, embedded in wax for HE staining, photographed and analysed under a microscope (Fig. 2A). Compared with the control group, the RDN group showed changes in the tissue structure of sympathetic nerve fibres around the renal artery, unevenly distributed and atrophied sympathetic ganglia, and fewer sympathetic ganglia. Tyrosine hydroxylase (TH) is a key enzyme in the synthesis of catecholamines and is distributed in the cytoplasm of adrenergic axons. Its positive expression can represent the activity of sympathetic nerves in local tissues. The effect of RDN on renal sympathetic nerves was observed using TH staining (Fig. 2B), and the results showed that the phenol chemical ablation method can damage the sympathetic nerves around the renal artery.

Fig. 2
figure 2

A shows the HE staining of sympathetic nerves around the renal artery of rats (HE × 200). Compared with the Control group, the structure of sympathetic nerve fibers around the renal artery in RDN group changed, the density of sympathetic ganglia was uneven, atrophied, and the number decreased. B shows the TH staining of the sympathetic nerves around the renal artery in rats (TH×200). Compared with the Control group, the sympathetic nerve activity around the renal artery in the RDN group decreased

Full size image

TH staining and NGF staining were used to evaluate cardiac sympathetic activity

TH staining of paraffin-embedded myocardial tissue sections revealed that the expression of TH in myocardial tissue decreased significantly in the RDN groups compared with the AMI group (Fig. 3). NGF regulates the growth and development of peripheral and central neurons and maintains neuronal survival. Staining for NGF can reflect the functional state of local tissue nerves. Compared with that in the AMI group, the expression of NGF in myocardial tissue decreased after RDN (Fig. 4).

Fig. 3
figure 3

Shows the TH staining of the rat hearts in each group (TH × 200). Compared with the AMI group, the expression of TH in the RDN group was significantly reduced

Full size image
Fig. 4
figure 4

Shows the myocardial NGF staining of rats in each group. Compared with the control group, the expression of NGF increased after AMI and the distribution was uneven; compared with the AMI group, the expression of NGF decreased after RDN, and the decrease in the RDN-2w+AMI group was more obvious

Full size image

Western blotting was used to detect NGF expression in the infarcted myocardium

NGF protein expression was upregulated in the AMI group compared with the control group and downregulated in the RDN-2w + AMI group compared with the AMI group. However, NGF protein expression was not downregulated in the RDN-1d + AMI group (Fig. 5).

Fig. 5
figure 5

Shows blot image and relative expression level of NGF, a–d Represent the control group, the AMI group, the RDN-1d + AMI group, and the RDN-2w + AMI group, respectively.(Original blot image，see additional file 1-4.)

Full size image

Detection of renal sympathetic nerve activity

The renal sympathetic nerve discharge signal was recorded by a Power Lab/8SP instrument. Compared with that in the control group (11.9 ± 0.5), the renal sympathetic nerve discharge in the RDN-1d + AMI group was significantly decreased (6.6 ± 1.5, P < 0.001). The renal sympathetic nerve discharge was also significantly reduced in the RDN-2w + AMI group (8.0 ± 2.5, P = 0.033), and the discharge reduction was more obvious in the RDN-1d + AMI group (Fig. 6).

Fig. 6
figure 6

A is the sample of renal sympathetic nerve discharge in each group, B is the activity of renal sympathetic nerve discharge, #Compared with the control group, the renal sympathetic nerve discharge in the RDN-1d group was significantly reduced (P<0.001);*Compared with the control group, the renal sympathetic nerve discharge in the RDN-2w group was also significantly decreased (P=0.033)

Full size image

The effect of RDN on NE levels in cerebrospinal fluid

Compared with that of the control group, the level of NE in the cerebrospinal fluid of the AMI group was significantly increased (P < 0.001). Moreover, compared with that of the AMI group, the level of NE in the cerebrospinal fluid of the RDN-1d + AMI group was significantly decreased (P < 0.001), while the level of NE in the cerebrospinal fluid of the RDN-2w + AMI group was significantly lower than that of the RDN-1d + AMI group (P < 0.001) (Table 1).

Table 1 Comparison of NE content in cerebrospinal fluid of each group (\(\overline{x }\)±s)
Full size table

The effect of RDN on the levels of NE, GABA and glutamate in the hypothalamus

Compared with those of the control group, the levels of NE and glutamate in the hypothalamus of the AMI group was significantly increased (P < 0.001), while the level of GABA was decreased (P < 0.001). Compared with those of the AMI group, NE and glutamate levels in the hypothalamus of the RDN-1d + AMI group and RDN-2w + AMI group decreased (P < 0.001), and the GABA level increased (P < 0.001). There was no significant difference in the levels of the three neurotransmitters in the hypothalamus between the RDN-1d + AMI group and the RDN-2w + AMI group (P > 0.05) (Table 2).

Table 2 Comparison of the contents of NE, GABA and glutamate in the hypothalamus of each group (\(\overline{x}\) ± s)
Full size table

Discussion

The mechanism of ventricular arrhythmia caused by AMI is not clear, but it is generally believed that the sympathetic nerve plays a key role in arrhythmia [16] and that inhibiting sympathetic nerve activity may reduce arrhythmia during ischemia/AMI [17]. AMI leads to nerve damage. Then, the sympathetic nerve sprouts to the ischaemic area, and ischaemic stimulation at the edge of the infarct leads to local hyperinnervation of the myocardium. The combined effect of enhanced sympathetic nerve germination and electrical remodelling of the myocardium is a possible cause of ventricular tachycardia, ventricular fibrillation and sudden cardiac death [18]. RDN damages renal sympathetic nerves, reduces sympathetic nerve activity and inhibits the RAAS system; it is widely used to treat clinical cardiovascular diseases, including hypertension and heart failure [19, 20]. Previous studies have found that RDN can inhibit myocardial remodelling and cardiac electrical remodelling after AMI [21] and can reduce arrhythmias during myocardial ischaemia [7]. In this study, the rats were pretreated with RDN, and then the AMI model was established to compare the occurrence of ventricular arrhythmia during ischemia/AMI. The current study showed that the frequency of ventricular tachycardia in the RDN groups was significantly reduced, and the effect was more pronounced in the RDN-1d + AMI group. During the experiment, one rat in the AMI group died of ventricular fibrillation, although none of the rats in the RDN groups died of ventricular fibrillation, showing that RDN can inhibit the occurrence of ventricular arrhythmia after AMI, thereby reducing mortality.Moreover, our study shows that RDN may reduce the afferent of renal sympathetic nerve impulses, inhibit central sympathetic nerve activity and cardiac sympathetic activity caused by AMI,thereby reducing ischaemic AMI arrhythmias(Fig. 7).

Fig. 7
figure 7

Central illustration figure

Full size image

Nerve sprouting and sympathetic excitation after myocardial infarction play an important role in the occurrence of arrhythmia. Studies have reported that inhibiting nerve remodelling after AMI can effectively reduce the occurrence of arrhythmia in rats [22, 23]. Partial myocardial denervation by interventional surgery can effectively prevent AMI-induced ventricular arrhythmias [2]. Enhanced sympathetic nervous system activity of secreted NE is known to bind to β receptors and thus promote the expression of Th and NGF [24].Our study found that AMI can lead to an increase in the expression of TH and NGF in myocardial tissue, which is similar to previous studies [25, 26],indicating that the activity of the cardiac local sympathetic nerve in the AMI group was enhanced. The expression of TH and NGF in myocardial tissue after RDN was lower than after AMI without RDN, especially in the RDN-2w + AMI group. This finding indicates that RDN can inhibit the abnormal excitation of cardiac sympathetic nerves caused by AMI, which is similar to the results of previous studies [27,28,29,30]. Compared with RDN-1d + AMI group, NGF decreased more significantly in RDN-2 W + AMI group, suggesting that RDN may not change the expression of Th and NGF immediately, with a hysteresis. Wanying Jiang et al. [31] found that RDN significantly reduced the expression of Th and connexin 43 in the infarct zone of AMI rats compared with metoprolol, which suggests that RDN may not only decrease myocardial sympathetic activity in AMI via NE/β receptor signaling pathway, but may also be associated with the inhibition of inflammation, the RASS system [27, 32].However, the mechanism by which RDN weakens the sympathetic activity of myocardial tissue is not clear.

The central nervous system can be divided into high-level and low-level centres; the low-level centre is located in the spinal cord, and the high-level centre is located in the hypothalamus, the brainstem and the reticular formation. The paraventricular nucleus (PVN) of the hypothalamus plays a major role in central cardiovascular and volume control and regulates sympathetic nerves [33]. Activating the sympathetic nerve by stimulating the PVN can reduce the threshold and increase the occurrence of ventricular fibrillation [34]. Glutamate can act on the PVN to cause sympathetic excitation, and its effect can be inhibited by GABA [35]. Interestingly, the inhibition of PVN activity can reduce arrhythmia in AMI rats [36]. Our study found that after AMI, the level of NE in the hypothalamus and cerebrospinal fluid increased; moreover, the level of the excitatory neurotransmitter glutamate also increased in the hypothalamus, while the level of the inhibitory neurotransmitter GABA decreased in the hypothalamus. RDN can inhibit the increase in NE and glutamate levels caused by AMI and increase the level of GABA in the hypothalamus, which has been reported in previous studies [37] and once again indicates that RDN can reduce central sympathetic nerve activity.

In this study, the discharge of renal sympathetic nerve was significantly reduced after RDN, which means that after RDN, the nerve impulse transmitted from the renal sympathetic nerve to the central nervous system was reduced. RDN damages renal sympathetic nerve, resulting in reduced discharge of it [38], compared with RDN-2 W + AMI group, the discharge of RDN-1d + AMI group decreased more significantly, which may be caused by the self-compensation of preserved nerves.Hong Zheng et al. [39] found that the outflow of the lumbar sympathetic nerve decreased after RDN. This finding, combined with the results of the current study, shows that RDN may reduce central sympathetic nerve activity by reducing the activity of the peripheral sympathetic nerve via a reduction in afferent renal sympathetic nerve activity. This is also a possible mechanism of the relative weakening of cardiac sympathetic activity and the reduction in the occurrence of ventricular arrhythmia in RDN rats after AMI. Interestingly, compared with the RDN-2w + AMI group, the RDN-1d + AMI group showed fewer arrhythmias, lower levels of NE or glutamate in the hypothalamus and cerebrospinal fluid, while the cardiac sympathetic activity in the RDN-2w + AMI group was lower than that in the RDN-1d + AMI group, which suggests that ischemia/AMI-arrhythmias may not only be dependent on central sympathetic excitation.

Conclusion

The above results suggest that the possible mechanism by which RDN inhibits ventricular arrhythmia caused by AMI is a reduction in afferent renal sympathetic nerve impulses and inhibition of the central sympathetic nerve activity caused by AMI. Then, the central nervous system reduces sympathetic output, thereby reducing cardiac sympathetic activity and the occurrence of ventricular arrhythmia caused by AMI.

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

AMI:

Acute myocardial infarction

ECG:

Electrocardiogram

ELISA:

Enzyme-linked immunosorbent assay

GABA:

γ-Aminobutyric acid

NE:

Norepinephrine

NGF:

Nerve growth factor

PVN:

Paraventricular nucleus

RDN:

Renal denervation

RAAS:

Renin angiotensin aldosterone system

RSNA:

Renal sympathetic nerve activity

TH:

Tyrosine-hydroxylase

References

  1. Rubart M, Zipes DP. Mechanisms of sudden cardiac death. J Clin Invest. 2005;115(9):2305.

    Article  CAS  Google Scholar 

  2. Chen J, Li M, Yu Y, Wu X, Jiang R, Jin Y, et al. Prevention of ventricular arrhythmia complicating acute myocardial infarction by local cardiac denervation. Int J Cardiol. 2015;184:667.

    Article  Google Scholar 

  3. Fukuta H, Goto T, Wakami K, Kamiya T, Ohte N. Effects of catheter-based renal denervation on heart failure with reduced ejection fraction: a meta-analysis of randomized controlled trials. Heart Fail Rev. 2020.

  4. Bradfield JS, Vaseghi M, Shivkumar K. Renal denervation for refractory ventricular arrhythmias. Trends Cardiovasc Med. 2014;24(5):206.

    Article  Google Scholar 

  5. Linz D, Ukena C, Wolf M, Linz B, Mahfoud F, Bohm M. Experimental evidence of the role of renal sympathetic denervation for treating atrial fibrillation. J Atr Fibrillation. 2014;7(3):1128.

    Google Scholar 

  6. Hoogerwaard AF, Elvan A. Is renal denervation still a treatment option in cardiovascular disease? Trends Cardiovasc Med. 2020;30(4):189.

    Article  Google Scholar 

  7. Linz D, Wirth K, Ukena C, Mahfoud F, Poss J, Linz B, et al. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs. Heart Rhythm. 2013;10(10):1525.

    Article  Google Scholar 

  8. Remo BF, Preminger M, Bradfield J, Mittal S, Boyle N, Gupta A, et al. Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia storm in patients with cardiomyopathy. Heart Rhythm. 2014;11(4):541.

    Article  Google Scholar 

  9. Armaganijan LV, Staico R, Moreira DA, Lopes RD, Medeiros PT, Habib R, et al. 6-Month outcomes in patients with implantable cardioverter-defibrillators undergoing renal sympathetic denervation for the treatment of refractory ventricular arrhythmias. JACC Cardiovasc Interv. 2015;8(7):984.

    Article  Google Scholar 

  10. Evranos B, Canpolat U, Kocyigit D, Coteli C, Yorgun H, Aytemir K. Role of adjuvant renal sympathetic denervation in the treatment of ventricular arrhythmias. Am J Cardiol. 2016;118(8):1207.

    Article  Google Scholar 

  11. Ukena C, Mahfoud F, Ewen S, Bollmann A, Hindricks G, Hoffmann BA, et al. Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry. Clin Res Cardiol. 2016;105(10):873.

    Article  CAS  Google Scholar 

  12. Jiang Z, Zhou X, Chen C, Wang Y, Fang P, Geng J, et al. Renal denervation for ventricular arrhythmia in patients with implantable cardioverter defibrillators. Int Heart J. 2018;59(2):328.

    Article  Google Scholar 

  13. Bradfield JS, Hayase J, Liu K, Moriarty J, Kee ST, Do D, et al. Renal denervation as adjunctive therapy to cardiac sympathetic denervation for ablation refractory ventricular tachycardia. Heart Rhythm. 2020;17(2):220.

    Article  Google Scholar 

  14. Hu J, Li Y, Cheng W, Yang Z, Wang F, Lv P, et al. A comparison of the efficacy of surgical renal denervation and pharmacologic therapies in post-myocardial infarction heart failure. PLoS ONE. 2014;9(5):e96996.

    Article  Google Scholar 

  15. Tan X, Jiao PL, Wang YK, Wu ZT, Zeng XR, Li ML, et al. The phosphoinositide-3 kinase signaling is involved in neuroinflammation in hypertensive rats. CNS Neurosci Ther. 2017;23(4):350.

    Article  CAS  Google Scholar 

  16. Verschure DO, van Eck-Smit BL, Somsen GA, Knol RJ, Verberne HJ. Cardiac sympathetic activity in chronic heart failure: cardiac (123)I-mIBG scintigraphy to improve patient selection for ICD implantation. Neth Heart J. 2016;24(12):701.

    Article  CAS  Google Scholar 

  17. Wang S, Gao H, Ru Z, Zou Y, Li Y, Cao W, et al. Poor Sleep quality associated with high risk of ventricular tachycardia after acute myocardial infarction. Nat Sci Sleep. 2019;11:281.

    Article  Google Scholar 

  18. Noordzij W, Elvan A, Demirel F, Jager PL, Tio RA, Slart RH. Sympathetic denervation in patients with ischemic cardiomyopathy and risk on ventricular tachy-arrhythmias: a pilot study. Q J Nucl Med Mol Imaging. 2018;62(4):429.

    Article  Google Scholar 

  19. Bergland OU, Soraas CL, Larstorp A, Halvorsen LV, Hjornholm U, Hoffman P, et al. The randomised Oslo study of renal denervation vs. Antihypertensive drug adjustments: efficacy and safety through 7 years of follow-up. Blood Press. 2021;30(1):41.

    Article  CAS  Google Scholar 

  20. Kresoja KP, Rommel KP, Fengler K, von Roeder M, Besler C, Lucke C, et al. Renal sympathetic denervation in patients with heart failure with preserved ejection fraction. Circ Heart Fail. 2021;14(3):e7421.

    Article  Google Scholar 

  21. Wang L, Wei G, Song L, Li C, Zhang F, Yang Y, et al. Effect of renal sympathetic denervation on ventricular and neural remodeling. Herz. 2019;44(8):717.

    Article  CAS  Google Scholar 

  22. Yang L, Zhang P, Chen X, Li C, Sun J, Hou J, et al. Semaphorin 3a transfection into the left stellate ganglion reduces susceptibility to ventricular arrhythmias after myocardial infarction in rats. Europace. 2015:v276.

  23. Wang H, Zhang Y, Guo S, Wu J, Lin W, Zhang B, et al. Effects of Yiqi Huoxue decoction on post-myocardial infarction cardiac nerve remodeling and cardiomyocyte hypertrophy in rats. Evid Based Complement Alternat Med. 2021;2021:5168574.

    Google Scholar 

  24. Winston JH, Sarna SK. Enhanced sympathetic nerve activity induced by neonatal colon inflammation induces gastric hypersensitivity and anxiety-like behavior in adult rats. Am J Physiol Gastrointest Liver Physiol. 2016;311(1):G32.

    Article  Google Scholar 

  25. Zhou M, Liu Y, Xiong L, Quan D, He Y, Tang Y, et al. Cardiac sympathetic afferent denervation protects against ventricular arrhythmias by modulating cardiac sympathetic nerve activity during acute myocardial infarction. Med Sci Monit. 2019;25:1984.

    Article  CAS  Google Scholar 

  26. Xiong L, Liu Y, Zhou M, Wang G, Quan D, Shen C, et al. Targeted ablation of cardiac sympathetic neurons improves ventricular electrical remodelling in a canine model of chronic myocardial infarction. Europace. 2018;20(12):2036.

    Article  Google Scholar 

  27. Feng Q, Lu C, Wang L, Song L, Li C, Uppada RC. Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs. BMC Cardiovasc Disord. 2017;17(1):65.

    Article  Google Scholar 

  28. Jackson N, Gizurarson S, Azam MA, King B, Ramadeen A, Zamiri N, et al. Effects of renal artery denervation on ventricular arrhythmias in a postinfarct model. Circ Cardiovasc Interv. 2017;10(3):e4172.

    Article  Google Scholar 

  29. Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, et al. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension. Clin Res Cardiol. 2016;105(4):364.

    Article  Google Scholar 

  30. Berukstis A, Vajauskas D, Gargalskaite U, Misonis N, Burneikaite G, Zakarkaite D, et al. Impact of renal sympathetic denervation on cardiac sympathetic nerve activity evaluated by cardiac MIBG imaging. EuroIntervention. 2016;11(9):1070.

    Article  Google Scholar 

  31. Jiang W, Chen C, Huo J, Lu D, Jiang Z, Geng J, et al. Comparison between renal denervation and metoprolol on the susceptibility of ventricular arrhythmias in rats with myocardial infarction. Sci Rep. 2018;8(1):10206.

    Article  Google Scholar 

  32. Li C, Xia W, Wang L, Zhang J, He Q, Liu Y, et al. Effect of renal denervation on cardiac function and inflammatory factors in heart failure after myocardial infarction. J Cardiovasc Pharmacol. 2020;76(5):602.

    Article  CAS  Google Scholar 

  33. Ramchandra R, Hood SG, Frithiof R, McKinley MJ, May CN. The role of the paraventricular nucleus of the hypothalamus in the regulation of cardiac and renal sympathetic nerve activity in conscious normal and heart failure sheep. J Physiol. 2013;591(1):93.

    Article  CAS  Google Scholar 

  34. Verrier RL, Calvert A, Lown B. Effect of posterior hypothalamic stimulation on ventricular fibrillation threshold. Am J Physiol. 1975;228(3):923.

    Article  CAS  Google Scholar 

  35. Llewellyn T, Zheng H, Liu X, Xu B, Patel KP. Median preoptic nucleus and subfornical organ drive renal sympathetic nerve activity via a glutamatergic mechanism within the paraventricular nucleus. Am J Physiol Regul Integr Comp Physiol. 2012;302(4):R424.

    Article  CAS  Google Scholar 

  36. Chen J, Yin D, He X, Gao M, Choi Y, Luo G, et al. Modulation of activated astrocytes in the hypothalamus paraventricular nucleus to prevent ventricular arrhythmia complicating acute myocardial infarction. Int J Cardiol. 2020;308:33.

    Article  Google Scholar 

  37. Nishihara M, Takesue K, Hirooka Y. Renal denervation enhances GABA-ergic input into the PVN leading to blood pressure lowering in chronic kidney disease. Auton Neurosci. 2017;204:88.

    Article  CAS  Google Scholar 

  38. Hearon C, Howden EJ, Fu Q, Yoo JK, Dias KA, Roberts-Reeves MA, et al. Evidence of reduced efferent renal sympathetic innervation after chemical renal denervation in humans. AM J Hypertens. 2021;34(7):744.

    Article  CAS  Google Scholar 

  39. Zheng H, Katsurada K, Liu X, Knuepfer MM, Patel KP. Specific afferent renal denervation prevents reduction in neuronal nitric oxide synthase within the paraventricular nucleus in rats with chronic heart failure. Hypertension. 2018;72(3):667.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by The Shanghai Key Medical Specialties Construction Project (ZK2019A11); Clinical Advantage Discipline of Health System of Putuo District in Shanghai (2019ysxk01);Medical innovation research project of “scientific and technological innovation action plan” (21Y11909600); Young Elite Scientists Sponsorship Program by CAST(QNRC2-B03);Shanghai Municipal Health and Health Commission Health Industry Clinical Research Project(201840247);Shanghai Municipal Health and Health Commission Health Industry Clinical Research Project(20214Y0494). All the funding bodies above were responsible for the approval of the study, did not participant in the design of the study or collection, analysis, and interpretation of data or in writing the manuscript.

Author information

Author notes

  1. Jian Ye and Rongxue Xiao contributed equally to this work

Authors and Affiliations

  1. Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University, Shanghai, 200062, People’s Republic of China

    Rongxue Xiao & Zongjun Liu

  2. The Fifth School of Clinical Medicine, Anhui Medical University, Shanghai, 200062, People’s Republic of China

    Rongxue Xiao & Zongjun Liu

  3. Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, People’s Republic of China

    Jian Ye, Rongxue Xiao, Xu Wang, Ruiqing He, Zongjun Liu & Junqing Gao

Authors
  1. Jian Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rongxue Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruiqing He
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zongjun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Junqing Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.G. and Z.L. conceived and designed the research. J.Y. and R.X. contributed to data collection, analysis and interpretation and drafted the paper; X.W. and R.H. contributed to data collection and analysis. All authors have read and approved the final manuscript.

Corresponding authors

Correspondence to Zongjun Liu or Junqing Gao.

Ethics declarations

Ethics approval and consent to participate

All procedures were approved by the Animal Care and Use Committee of the putuo hospital affiliated to Shanghai University of Traditional Chinese Medicine. Reference number: 2020pt-02.

Consent for publication

Not applicable.

Competing interests

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1

. (Cuted blot images).

Additional file 2

. (Original blot images).

Additional file 3

. (Original blot images).

Additional file 4

. (Original blot images).

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ye, J., Xiao, R., Wang, X. et al. Effects and mechanism of renal denervation on ventricular arrhythmia after acute myocardial infarction in rats. BMC Cardiovasc Disord 22, 544 (2022). https://doi.org/10.1186/s12872-022-02980-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12872-022-02980-4

Keywords

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us